CTSH · Cognizant Technology Solutions Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $21.11B | $19.74B | $19.35B | $19.43B | $18.51B | $16.65B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $3.24B | $3.22B | $3.25B | $3.44B | $3.50B | $3.10B |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $550.00M | $542.00M | $555.00M | $569.00M | $574.00M | $559.00M |
| Operating Income | $3.39B | $2.89B | $2.69B | $2.97B | $2.83B | $2.11B |
| Interest Expense | $37.00M | $54.00M | $41.00M | $19.00M | $9.00M | $24.00M |
| Income Tax | $1.26B | $713.00M | $668.00M | $730.00M | $693.00M | $704.00M |
| Net Income | $2.23B | $2.24B | $2.13B | $2.29B | $2.14B | $1.39B |
| EPS - Basic | $4.57 | $4.52 | $4.21 | $4.42 | $4.06 | $2.58 |
| EPS - Diluted | $4.56 | $4.51 | $4.21 | $4.41 | $4.05 | $2.57 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.90B | $2.23B | $2.62B | $2.19B | $1.79B | $2.68B |
| Accounts Receivable | $4.44B | $4.06B | $3.85B | $3.80B | $3.56B | $3.09B |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $308.00M | $340.00M | $337.00M | $360.00M | $361.00M | $389.00M |
| Current Assets | $7.82B | $7.50B | $7.51B | $7.27B | $7.34B | $6.85B |
| Total Assets | $20.69B | $19.97B | $18.48B | $17.85B | $17.85B | $16.92B |
| Current Liabilities | $3.66B | $3.58B | $3.33B | $3.35B | $3.53B | $3.54B |
| Long-term Debt | $543.00M | $875.00M | $606.00M | $638.00M | $626.00M | $663.00M |
| Total Liabilities | $5.68B | $5.56B | $5.26B | $5.54B | $5.86B | $6.09B |
| Stockholders' Equity | $15.02B | $14.41B | $13.23B | $12.31B | $11.99B | $10.84B |
| Retained Earnings | $15.16B | $14.69B | $13.30B | $12.59B | $11.92B | $10.69B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.88B | $2.12B | $2.33B | $2.57B | $2.50B | $3.30B |
| Investing Cash Flow | ($230.00M) | ($1.65B) | ($331.00M) | ($106.00M) | ($2.16B) | ($1.24B) |
| Financing Cash Flow | ($2.27B) | ($915.00M) | ($1.61B) | ($1.94B) | ($1.20B) | ($2.01B) |
| CapEx | $288.00M | $297.00M | $317.00M | $332.00M | $279.00M | $398.00M |
| Free Cash Flow | $2.60B | $1.83B | $2.01B | $2.24B | $2.22B | $2.90B |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | 16.1% | 14.7% | 13.9% | 15.3% | 15.3% | 12.7% |
| EBITDA margin | 18.7% | 17.4% | 16.8% | 18.2% | 18.4% | 16.1% |
| Net margin | 10.6% | 11.3% | 11.0% | 11.8% | 11.5% | 8.4% |
| Free cash flow margin | 12.3% | 9.3% | 10.4% | 11.5% | 12.0% | 17.4% |
| FCF / Net income | 1.16 | 0.82 | 0.95 | 0.98 | 1.04 | 2.08 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 15.3% | 16.3% | 16.8% | 17.7% | 18.9% | 18.6% |
| Effective tax rate | 36.1% | 24.1% | 23.9% | 24.2% | 24.5% | 33.6% |
| Return on assets | 10.8% | 11.2% | 11.5% | 12.8% | 12.0% | 8.2% |
| Return on equity | 14.9% | 15.5% | 16.1% | 18.6% | 17.8% | 12.8% |
| Return on invested capital | 13.9% | 14.4% | 14.8% | 17.4% | 16.9% | 12.2% |
| Liquidity | ||||||
| Current ratio | 2.14 | 2.09 | 2.25 | 2.17 | 2.08 | 1.94 |
| Quick ratio | 2.14 | 2.09 | 2.25 | 2.17 | 2.08 | 1.94 |
| Cash ratio | 0.52 | 0.62 | 0.79 | 0.65 | 0.51 | 0.76 |
| Leverage | ||||||
| Debt / Equity | 0.04 | 0.06 | 0.05 | 0.05 | 0.05 | 0.06 |
| Debt / Assets | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
| Debt / EBITDA | 0.14 | 0.25 | 0.19 | 0.18 | 0.18 | 0.25 |
| Interest coverage | 91.6x | 53.6x | 65.6x | 156.2x | 314.0x | 88.1x |
| Equity multiplier | 1.38 | 1.39 | 1.40 | 1.45 | 1.49 | 1.56 |
| Liabilities / Assets | 0.27 | 0.28 | 0.28 | 0.31 | 0.33 | 0.36 |
| Efficiency | ||||||
| Asset turnover | 1.02 | 0.99 | 1.05 | 1.09 | 1.04 | 0.98 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | 77d | 75d | 73d | 71d | 70d | 68d |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 18.2x | 17.1x | 17.9x | 13.0x | 21.9x | 31.9x |
| P / B | 2.7x | 2.7x | 2.9x | 2.4x | 3.9x | 4.1x |
| P / S | 1.9x | 1.9x | 2.0x | 1.5x | 2.5x | 2.7x |
| EV / EBITDA | 10.0x | 10.7x | 11.1x | 8.0x | 13.4x | 15.8x |
| Growth | ||||||
| Revenue growth (YoY) | 7.0% | 2.0% | -0.4% | 5.0% | 11.1% | -0.8% |
| Revenue CAGR (3y) | 2.8% | 2.2% | 5.1% | 5.0% | 4.7% | 4.0% |
| Revenue CAGR (5y) | 4.9% | 3.3% | 3.7% | 5.6% | 6.5% | 6.0% |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | 17.2% | 7.5% | -9.4% | 5.0% | 33.7% | -13.8% |
| Net income growth (YoY) | -0.4% | 5.4% | -7.2% | 7.2% | 53.5% | -24.4% |
| EPS growth (YoY) | 1.1% | 7.1% | -4.5% | 8.9% | 57.6% | -21.9% |
| EPS CAGR (3y) | 1.1% | 3.7% | 17.9% | 10.3% | 4.0% | 0.5% |
| EPS CAGR (5y) | 12.2% | 6.5% | 3.2% | 11.8% | 9.7% | -0.6% |
| FCF growth (YoY) | 42.0% | -9.2% | -10.0% | 0.9% | -23.6% | 37.7% |
| FCF CAGR (5y) | -2.2% | -2.8% | -1.9% | 1.0% | 10.9% | 9.1% |
| Book value growth (YoY) | 4.2% | 8.9% | 7.5% | 2.7% | 10.7% | -1.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$21.11B totalHealth Sciences$6.35B · 30.1%
Financial Services$6.17B · 29.2%
Productsand Resources$5.29B · 25.0%
Communications Mediaand Technology$3.30B · 15.6%
Product / service
$6.35B totalConsulting And Technology Services$3.65B · 57.5%
Outsourcing Services$2.70B · 42.5%
Geographic
$7.23B totalNorth America$5.31B · 73.5%
Europe$881.00M · 12.2%
Europeexcluding United Kingdom$667.00M · 9.2%
GB$214.00M · 3.0%
Restof World$155.00M · 2.1%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
3.40
Safe
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
7/9
Strong
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✓Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-Computer Programming Services
Comparing COGNIZANT TECHNOLOGY SOLUTIONS CORP against the 5 most active filers in the same SIC group.
Dividends
$1.28/share trailing 12 months · +4.9% YoY
| Ex-date | Per share |
|---|---|
| May 18, 2026 | $0.3300 |
| Feb 18, 2026 | $0.3300 |
| Nov 18, 2025 | $0.3100 |
| Aug 18, 2025 | $0.3100 |
| May 19, 2025 | $0.3100 |
| Feb 18, 2025 | $0.3100 |
| Nov 19, 2024 | $0.3000 |
| Aug 20, 2024 | $0.3000 |
| May 17, 2024 | $0.3000 |
| Feb 16, 2024 | $0.3000 |
| Nov 20, 2023 | $0.2900 |
| Aug 18, 2023 | $0.2900 |
| May 18, 2023 | $0.2900 |
| Feb 16, 2023 | $0.2900 |
| Nov 17, 2022 | $0.2700 |
| Aug 18, 2022 | $0.2700 |
| May 19, 2022 | $0.2700 |
| Feb 17, 2022 | $0.2700 |
| Nov 18, 2021 | $0.2400 |
| Aug 19, 2021 | $0.2400 |
| May 19, 2021 | $0.2400 |
| Feb 17, 2021 | $0.2400 |
| Nov 18, 2020 | $0.2200 |
| Aug 20, 2020 | $0.2200 |